Curis Lifesciences Limited equity shares admitted to trading on NSE EMERGE SME Platform with effect from November 14, 2025 under Trade for Trade Surveillance Segment.
Impact
Medium
Severity
Medium
Justification
New SME listing on EMERGE platform with Trade for Trade surveillance measures. Impacts SME investors and market makers but limited broader market significance.